1. Home
  2. AYTU vs CPOP Comparison

AYTU vs CPOP Comparison

Compare AYTU & CPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • CPOP
  • Stock Information
  • Founded
  • AYTU N/A
  • CPOP 2007
  • Country
  • AYTU United States
  • CPOP China
  • Employees
  • AYTU N/A
  • CPOP N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • CPOP Services-Misc. Amusement & Recreation
  • Sector
  • AYTU Health Care
  • CPOP Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • CPOP Nasdaq
  • Market Cap
  • AYTU 9.6M
  • CPOP 9.4M
  • IPO Year
  • AYTU N/A
  • CPOP 2021
  • Fundamental
  • Price
  • AYTU $2.21
  • CPOP $0.58
  • Analyst Decision
  • AYTU Strong Buy
  • CPOP
  • Analyst Count
  • AYTU 1
  • CPOP 0
  • Target Price
  • AYTU $12.00
  • CPOP N/A
  • AVG Volume (30 Days)
  • AYTU 624.8K
  • CPOP 18.8K
  • Earning Date
  • AYTU 05-14-2025
  • CPOP 07-07-2025
  • Dividend Yield
  • AYTU N/A
  • CPOP N/A
  • EPS Growth
  • AYTU N/A
  • CPOP N/A
  • EPS
  • AYTU N/A
  • CPOP N/A
  • Revenue
  • AYTU $81,659,000.00
  • CPOP $47,381,918.00
  • Revenue This Year
  • AYTU N/A
  • CPOP N/A
  • Revenue Next Year
  • AYTU $8.68
  • CPOP N/A
  • P/E Ratio
  • AYTU N/A
  • CPOP N/A
  • Revenue Growth
  • AYTU 0.41
  • CPOP 155.52
  • 52 Week Low
  • AYTU $0.95
  • CPOP $0.46
  • 52 Week High
  • AYTU $2.96
  • CPOP $1.70
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 63.18
  • CPOP 46.05
  • Support Level
  • AYTU $2.04
  • CPOP $0.52
  • Resistance Level
  • AYTU $2.40
  • CPOP $0.59
  • Average True Range (ATR)
  • AYTU 0.14
  • CPOP 0.03
  • MACD
  • AYTU 0.00
  • CPOP -0.00
  • Stochastic Oscillator
  • AYTU 54.90
  • CPOP 35.56

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

Share on Social Networks: